Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

ClinicalTrials.gov ID: NCT05052996

Public ClinicalTrials.gov record NCT05052996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 10:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Open-Label, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy of oral weekly islatravir (ISL) in combination with lenacapavir (LEN) in virologically suppressed people with HIV (PWH) at Week 24.

Study identification

NCT ID
NCT05052996
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
142 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 5, 2021 (Actual)
Primary completion
Dec 19, 2023 (Actual)
Completion
Mar 2028 (Estimated)
Last update posted
Feb 4, 2026

2021 – 2028

United States locations

U.S. sites
44
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Pacific Oaks Medical Group Beverly Hills California 90211 —
Ruane Clinical Research Group, Inc Los Angeles California 90036 —
Mills Clinical Research Los Angeles California 90069 —
Hoag Medical Group - Newport Beach Newport Beach California 92663 —
BIOS Clinical Research Palm Springs California 92262 —
Optimus Medical Group San Francisco California 94102 —
Public Health Institute at Denver Health Denver Colorado 80204 —
Vivent Health Denver Colorado 80246 —
Washington Health Institute Washington D.C. District of Columbia 20017 —
The George Washington University Medical Faculty Associates Inc. Washington D.C. District of Columbia 20037 —
CAN Community Health Care, Inc. Fort Lauderdale Florida 33316 —
Midway Immunology and Research Center Ft. Pierce Florida 34982 —
JEM Research Institute Lake Worth Florida 33462 —
Schiff Center for Liver Diseases/University of Miami Miami Florida 33136 —
Floridian Clinical Research Miami Lakes Florida 33016 —
Orlando Immunology Center Orlando Florida 32803 —
Emory University Hospital Midtown Infectious Disease Clinic Atlanta Georgia 30308 —
Atlanta ID Group, PC Atlanta Georgia 30309 —
Metro Infectious Disease Consultants Decatur Georgia 30033 —
Chatham County Health Department Savannah Georgia 31401 —
John A. Burns School of Medicine, University of Hawaii Clinics at Kaka'ako Honolulu Hawaii 96813 —
Howard Brown Health Center Chicago Illinois 60613 —
Northstar Healthcare Chicago Illinois 60657 —
Indiana CTSI Clinical Research Center Indianapolis Indiana 46202 —
Boston Medical Center Boston Massachusetts 02118 —
AccessHealth MA Boston Massachusetts 02129 —
Be Well Medical Center Berkley Michigan 48072 —
Hennepin Healthcare HCMC New Brighton Minnesota 55112 —
Southampton Healthcare, Inc. St Louis Missouri 63139 —
Huntridge Family Clinic Las Vegas Nevada 89104 —
ID Care Hillsborough New Jersey 08844 —
AXCES Research Group Santa Fe New Mexico 87505 —
New York-Presbyterian Queens Flushing New York 11355 —
Jacobi Medical Center The Bronx New York 10461 —
NC TraCS Institute - CTRC: University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Penn Medicine: Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Philadelphia FIGHT Community Health Centers Philadelphia Pennsylvania 19107 —
Central Texas Clinical Research, LLC Austin Texas 78705 —
AIDS Arms Inc Dallas Texas 75208 —
North Texas Infectious Diseases Consultants, P.A. Dallas Texas 75246 —
The Crofoot Research Center, INC Houston Texas 77098 —
Peter Shalit, M.D. Seattle Washington 98104 —
MultiCare Rockwood Main Clinic Spokane Washington 99202 —
Community Health Care Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05052996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05052996 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →